Two Sigma Investments LP Buys 10,427 Shares of InfuSystem Holdings, Inc. (NYSE:INFU)

Two Sigma Investments LP grew its stake in shares of InfuSystem Holdings, Inc. (NYSE:INFU) by 40.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 36,252 shares of the company’s stock after acquiring an additional 10,427 shares during the quarter. Two Sigma Investments LP owned about 0.17% of InfuSystem worth $306,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of INFU. Nuveen Asset Management LLC lifted its position in shares of InfuSystem by 14.1% during the 4th quarter. Nuveen Asset Management LLC now owns 86,379 shares of the company’s stock worth $730,000 after buying an additional 10,647 shares during the last quarter. Meros Investment Management LP lifted its position in shares of InfuSystem by 2.6% during the 4th quarter. Meros Investment Management LP now owns 631,105 shares of the company’s stock worth $5,333,000 after buying an additional 16,178 shares during the last quarter. Millennium Management LLC lifted its position in shares of InfuSystem by 6.3% during the 4th quarter. Millennium Management LLC now owns 76,419 shares of the company’s stock worth $646,000 after buying an additional 4,532 shares during the last quarter. Deutsche Bank AG lifted its position in shares of InfuSystem by 148.3% during the 4th quarter. Deutsche Bank AG now owns 27,671 shares of the company’s stock worth $234,000 after buying an additional 16,526 shares during the last quarter. Finally, Corton Capital Inc. bought a new stake in shares of InfuSystem during the 4th quarter worth $130,000. 71.13% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages recently weighed in on INFU. Sidoti upgraded InfuSystem to a “strong-buy” rating in a research report on Tuesday, March 18th. B. Riley upgraded InfuSystem to a “strong-buy” rating in a research report on Thursday, May 8th. Finally, Wall Street Zen cut InfuSystem from a “strong-buy” rating to a “buy” rating in a report on Wednesday, May 14th.

InfuSystem Price Performance

Shares of INFU opened at $6.05 on Wednesday. InfuSystem Holdings, Inc. has a 12-month low of $4.61 and a 12-month high of $9.97. The business has a 50-day simple moving average of $5.32 and a two-hundred day simple moving average of $6.86. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. The stock has a market cap of $127.15 million, a PE ratio of 100.85 and a beta of 1.81.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.